Prurigo Nodularis clinical trials at UCSF
1 research study open to eligible people
Prurigo nodularis creates itchy, raised bumps on the skin. UCSF is testing the drug barzolvolimab to verify its effectiveness and safety for treating adults. The trials aim to improve treatment options for those with this condition.
Showing trials for
Barzolvolimab in Patients With Prurigo Nodularis
open to eligible people ages 18 years and up
The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with prurigo nodularis.
San Francisco, California and other locations
Last updated: